du HPV 6, 11, 16 et 18

G.LAMBLIN
P.MATHEVET
V.REMY
HPV vulvo vaginal
HFME LYON - Bron

Lésions vulvaires et vaginales en France
2006 données PMSI (France) database registre épidémiologie
1219 cancer vulvaire 701 cancer vagin
623 VIN (89% vin 3) 244 VIN (71% vain 3)
65% milieu hospitalier / 35% clinique
HPV vulvo vaginal
40% Cancer vulvaire et 70% Cancer vaginal : HPV

Number of stays
(% as primary
diagnosis)
Number of patients
(low estimate)*
Number of patients
hospitalized in day
hospital** setting
48h (%)
Number of patients
from public sector (%)
Number of patients
(corrected estimate)*
Vulvar cancer 1478 (84) 1219 405 (27,4) 815 (66.8) 1237
Vulvar dysplasia
Mild (VIN1) 65 (100) 59 54 (83,1) 33 (55.9) -
Moderate
(VIN2) (VIN1) (VIN2)
60 (97) 54 41 (68,3) 40 (74.1) -
Severe
(VIN3)
99 (99) 91 257 (50,2) 71 (78.0) -
Vulvar CIS 411 (99) 355 220 (62.0) -
VIN undetermined 66 (97) 64 37 (57.8) -
Vaginal cancer 903 (42) 701 335 (37,1) 467 (66.6) 728
Vaginal dysplasia
Mild (VaIN1) 63 (98) 61 51 (81,0) 25 (41.0) -
Moderate (VaIN2) 55 (100) 51 45 (81,8) 30 (58.8) -
Severe (VaIN3) 43 (100) 41 61 (52,6) 19 (46.3) -
Vaginal CIS 70 (99) 61 43 (70.5) -
VAIN undetermined 37 (100) 30 22 (73.3) -

0
5
10
15
20
25
30
35
<20 20-29 30-39 40-49 50-59 60-69 70-79 ≥80
Age (years)
%
Low grade VIN
High grade VIN
Vulvar cancer
Age distribution for low-grade vulvar intraepithelial neoplasia (VIN1), high-
grade VIN (VIN2, VIN3, or carcinoma in situ) and vulvar cancer

0
5
10
15
20
25
30
35
<20 20-29 30-39 40-49 50-59 60-69 70-79 ≥80
Age (years)
%
Low-grade VaIN
High-grade VaIN
Vaginal cancer
Age distribution for low-grade vaginal intraepithelial neoplasia (VaIN1),
high-grade VaIN (VaIN2, VaIN3, or carcinoma in situ) and vaginal cancer